The effects of NT1014, a novel AMPK activator, compared to metformin, on ovarian cancer cell proliferation, apoptosis, and tumor growth
Keyword(s):
Keyword(s):
2021 ◽
Vol 4
(2)
◽
pp. 744-756
2018 ◽
Vol 119
(9)
◽
pp. 7790-7799
◽
2020 ◽
Vol 51
(2)
◽
pp. 246-252
2019 ◽
Vol 12
◽
pp. 9-15
◽